How weight affects treatment for inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at whether body weight or obesity changes how well treatment works for people with inflammatory bowel disease (IBD), which causes inflammation in the digestive tract. If you have IBD and are already on treatment, this trial may help doctors understand how to personalize care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- You are currently receiving standard treatment, which may include biologic medicines.
- You are not pregnant.
- Your medical records have complete information about your diagnosis and follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors diagnose inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It may help improve diagnosis and care for people with IBD.
This study tests whether a personalized aerobic exercise program (like walking or cycling) can help people with mild or inactive Crohn's disease or ulcerative colitis feel better. It lasts 12 weeks and is designed for people who don't currently exercise regularly.
This study looks at whether a moderate exercise program can help people with inflammatory bowel disease (IBD) feel better and manage their condition. It aims to see if exercise improves overall health without worsening symptoms.
This study looks at how weight and body mass index (BMI) change in people with inflammatory bowel disease who are taking infliximab, and whether those changes affect treatment costs. It will help understand if weight affects how well the medicine works and what it costs.
This study looks at how diet affects inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It may help understand if certain foods can improve symptoms.
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.